FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

House Committee Seeks FDA Timelines on NECC Actions

[ Price : $8.95]

House Energy and Commerce Republican leaders ask FDA commissioner Margaret Hamburg for timelines and internal communications relat...

Public Citizen Calls for Probe on CMS Role in Compounding

[ Price : $8.95]

Public Citizens Health Research Group has called for an HHS Inspector General investigation into whether financial incentives crea...

HeartSine Class 1 Recall on Samaritan Defibrillators

[ Price : $8.95]

HeartSine begins a Class 1 recall involving certain Samaritan 300/300P Public Access Defibrillators after determining they may i...

FDA Approves Expanded Use for Glaxos Promacta

[ Price : $8.95]

FDA approves GlaxoSmithKlines Promacta for treating thrombocytopenia in patients with chronic hepatitis C.

FDA Amends Dates on Device ID System Rule

[ Price : $8.95]

Federal Register Notice: FDA amends its 7/10 proposed rule on a unique device identification system to change the proposed effecti...

Comments Sought on Custom Device Exemption

[ Price : $8.95]

Federal Register Notice: FDA seeks information on appropriate uses of the custom device exemption under the Food and Drug Administ...

ICH Guidance on Q11 Drug Substance Development

[ Price : $8.95]

A final ICH guidance on Q11 Development and Manufacture of Drug Substances describes approaches to developing and understanding th...

Judge Tosses Ex-Pfizer Employees Whistleblower Suit

[ Price : $8.95]

A federal judge dismisses a former Pfizer employee's whistleblower suit alleging that the company illegally promoted its cholester...

Dexcom Glucose Monitor Approved by FDA

[ Price : $8.95]

FDA approves Dexcoms continuous glucose monitoring system, the Dexcom G4 PLATINUM.

PolyMedix Receives FDA Guidance on Brilacidin

[ Price : $8.95]

PolyMedix receives guidance in a meeting with FDA on a Phase 2B protocol for its brilacidin in treating acute bacterial skin and s...